Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Article

  • Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
    Open Access
    Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
    Martina Arici, Mara Ferrandi, Paolo Barassi, Shih-Che Hsu, Eleonora Torre, Andrea Luraghi, Carlotta Ronchi, Gwo-Jyh Chang, Francesco Peri, Patrizia Ferrari, Giuseppe Bianchi, Marcella Rocchetti and Antonio Zaza
    Journal of Pharmacology and Experimental Therapeutics January 2023, 384 (1) 231-244; DOI: https://doi.org/10.1124/jpet.122.001335
  • Open Access
    A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
    Joseph Kuo, Michael Bobardt, Udayan Chatterji, Patrick R. Mayo, Daniel J. Trepanier, Robert T. Foster, Philippe Gallay and Daren R. Ure
    Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 231-241; DOI: https://doi.org/10.1124/jpet.119.261099
  • You have access
    Reduction of 5-Hydroxytryptamine (5-HT)1A-Mediated Temperature and Neuroendocrine Responses and 5-HT1A Binding Sites in 5-HT Transporter Knockout Mice
    Qian Li, Christine Wichems, Armin Heils, Louis D. Van de Kar, Klaus-Peter Lesch and Dennis L. Murphy
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 999-1007;
  • You have access
    Prolonged Inhibition ofO 6-Methylguanine DNA Methyltransferase in Human Tumor Cells by O 6-Benzylguanine In Vitro and In Vivo
    Emiko L. Kreklau, Chandrika Kurpad, David A. Williams and Leonard C. Erickson
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1269-1275;
  • You have access
    Neural and Endocrine Mechanisms Mediating Noxious Stimulus-Induced Inhibition of Bradykinin Plasma Extravasation in the Rat
    Frederick Jia-Pei Miao and Jon D. Levine
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1028-1037;
  • You have access
    l-Glutamate and γ-Aminobutyric Acid Efflux from Rat Cerebrocortical Synaptosomes: Modulation by κ- and μ- but Not δ- and Opioid Receptor Like-1 Receptors
    Simone Sbrenna, Matteo Marti, Michele Morari, Girolamo Calo, Remo Guerrini, Lorenzo Beani and Clementina Bianchi
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1365-1371;
  • You have access
    Antagonist-Induced Reversal of Functional and Structural Measures of Hippocampal Benzodiazepine Tolerance
    Elizabeth I. Tietz, Xu J. Zeng, Shanyi Chen, Scott M. Lilly, Howard C. Rosenberg and Peter Kometiani
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 932-942;
  • You have access
    Powerful Activation of Skeletal Muscle Actomyosin ATPase by Goniodomin A Is Highly Sensitive to Troponin/Tropomyosin Complex
    Kimihiro Matsunaga, Keigo Nakatani, Masahiro Murakami, Katsumi Yamaguchi and Yasushi Ohizumi
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1121-1126;
  • You have access
    Ethnic Differences in N-Glucuronidation of Nicotine and Cotinine
    Neal L. Benowitz, Eliseo J. Perez-Stable, Irving Fong, Gunnard Modin, Brenda Herrera and Peyton Jacob
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1196-1203;
  • You have access
    4-Methylcatechol Increases Brain-Derived Neurotrophic Factor Content and mRNA Expression in Cultured Brain Cells and in Rat Brain In Vivo
    Atsumi Nitta, Megumi Ito, Hidefumi Fukumitsu, Makoto Ohmiya, Hisanori Ito, Ayako Sometani, Hiroshi Nomoto, Yoshiko Furukawa and Shoei Furukawa
    Journal of Pharmacology and Experimental Therapeutics December 1999, 291 (3) 1276-1283;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 1057
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics